Oasis500 invests in Pi Pharma Intelligence
InvestmentsPi Pharma Intelligence joined the Oasis500 portfolio of companies Pi Pharma Intelligence has received a seed investment from Oasis500. This investment will be utilized to enable the commercial launch of the company in the region and finalizing the company HR structure needed for the short term objectives. Pi Pharma Intelligence is grateful for the trust of Oasis500 on its vision and assets.
Thrilled to see our CEO, Nusaibah Al-Jaloudi, on stage sharing insights about AI in pharmaceutical digitization at the GCC Regulatory Affairs Pharma Summit!
May, 2024
Thrilled to see our CEO, Nusaibah Al-Jaloudi, on stage sharing insights about AI in pharmaceutical digitization at the GCC Regulatory Affairs Pharma Summit!
Pi Pharma Intelligence will attend Pharma Synergy 2024
Dec, 2023
Pi Pharma Intelligence will attend Pharma Synergy 2024
Announcing a New Era of Leadership at Pi Pharma Intelligence!
Feb, 2025
As we step into an exciting new chapter, we are proud to unveil the evolution of our leadership team, dedicated to driving innovation and shaping the future of pharmaceutical intelligence.